• Publications
  • Influence
[Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations].
OBJECTIVE To investigate the incidence, survival, and influential factors of lung cancer in the Shanghai populations. METHODS Data of individual cases of lung cancer 2000 - 2004 were obtained fromExpand
  • 10
  • 1
A Cost-Effectiveness Analysis of Docetaxel versus Pemetrexed in Second-Line Chemotherapy for Stage IIIb or IV Non-Small Cell Lung Cancer in China
  • Y. Yu, Z. Chen, +5 authors Shun Lu
  • Biology, Medicine
  • Chemotherapy
  • 2010
Background: To study the cost-efficacy of docetaxel and pemetrexed as single agents versus platinum-based combination agents in second-line treatment of stage IIIb or IV non-small cell lung cancerExpand
  • 8
  • 1
Erlotinib as a salvage treatment for patients with advanced non-small cell lung cancer after failure of gefitinib treatment.
BACKGROUND Several clinical trials showed that erlotinib was effective after the failure of gefitinib in advanced non-small cell lung cancer (NSCLC). The aim of this study was to evaluate theExpand
  • 11
The effects of cetuximab alone and in combination with endostatin on vascular endothelial growth factor and interleukin-8 expression in human lung adenocarcinoma cells.
BACKGROUND Angiogenesis, the growth of new blood vessels, plays an important role in tumor growth and metastasis. Both cetuximab and endostatin have been found to reduce the expression ofExpand
  • 4
  • PDF
Maintenance therapy for NSCLC: Consensus and controversy
  • Shun Lu, Y. Yu
  • Medicine
  • Chinese journal of cancer research = Chung-kuo…
  • 22 December 2011
Nowadays, advanced non-small cell lung cancer (NSCLC) is still an incurable disease. However, recent researches on maintenance therapy have led to considerable progress. Recently, pemetrexed andExpand
  • 7
XBP1-LOX Axis is critical in ER stress-induced growth of lung adenocarcinoma in 3D culture.
  • Y. Yang, B. Cheng, +6 authors Shun Lu
  • Medicine
  • American journal of translational research
  • 2017
Rapid growth of tumor cells needs to consume large amounts of oxygen and glucose, due to lack of blood supply within the tumor, cells live in an environment that lack of oxygen and nutrients. ThisExpand
  • 2
Guidelines for lung cancer in 2015: Consensus and controversy
The standardization of diagnosis and treatment of lung cancer has important significance for improving the prognosis of patients with lung cancer. A thorough and accurate interpretation of theExpand
  • 1
[Comparison of single-agent docetaxel versus docetaxel plus platinum combination agent in second-line treatment for advanced non-small cell lung cancer].
  • Y. Zhang, Y. Yu, Shun Lu
  • Medicine
  • Zhonghua yi xue za zhi
  • 9 June 2009
OBJECTIVE To compare the therapeutic efficacies and toxicities of single-agent docetaxel or docetaxel plus platinum combination agent in patients with advanced non-small cell lung cancer (NSCLC) soExpand
  • 2
Discrepancy of biologic behavior influenced by bone marrow derived cells in lung cancer.
Disseminated cancer cells may initially require local nutrients and growth factors to thrive and survive in bone marrow. However, data on the influence of bone marrow derived cells (BMDC, also calledExpand
  • 1
  • PDF